Rinkey Investments’s DermTech, Inc. Common Stock DMTK Stock Holding History

Rinkey Investments’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	277
2021 Q4	$0	Buy	+1	New	+$24	﹤0.01%	288

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Rinkey Investments's DMTK Position: Q1 2022 in Review

Rinkey Investments sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 1 share.

Rinkey Investments first reported a position in DMTK in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 151 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

Rinkey Investments reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Rinkey Investments sold 1 DermTech, Inc. Common Stock share in Q1 2022.
Rinkey Investments first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Rinkey Investments's DermTech, Inc. Common Stock position peaked at $0 in Q4 2021.
151 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Rinkey Investments's 13F filing for Q1 2022, filed 9 May 2022.